CLINICAL_TRIALS
trial_result
· 2021-02-17
Clinical Trial Update: A Study of Olaratumab in Japanese Participants With Advanced Cancer [Phase 1]
Summary
Phase 1 trial update of olaratumab in Japanese participants with advanced cancer has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Neoplasm | Phase 1 | Status: COMPLETED | Results posted: 2021-02-17